Lobby organisation
Zimmer Biomet Holdings
Business / industry · Health & pharma · HQ: Switzerland · Transparency Register entry
As of 9 September 2026, Zimmer Biomet Holdings appears in 23 declared MEP meetings (16 different MEPs), most often with European People's Party.
In their own words
“Zimmer Biomet (NYSE: ZBH) is a publicly traded medical device company. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. Founded in 1927, Zimmer Biomet is a world leader in orthopaedic implantable devices. Zimmer Biomet designs, develops, manufactures and markets orthopaedics products, including knee, hip, shoulder, elbow, foot and ankle artificial joints…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 23 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (8 in 2024).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 8 Sep 2026 | Aurelijus Veryga | Medical Devices Regulation and the Commission’s Draft Revision Proposal |
| 14 Apr 2026 | Tiemo Wölken | MDR/IVDR |
| 17 Feb 2026 | Dan-Ştefan Motreanu | Medical Devices |
| 16 Feb 2026 | Victor Negrescu | Discussion on the revision of the EU Medical Devices Regulation (MDR) |
| 5 Feb 2026 | Marion Walsmann | Digitaler Omnibus, KI und MDR-Revision |
| 3 Feb 2026 | Axel Voss | Stakeholder meeting on AI Omnibus |
| 8 Jan 2026 | Andrea Wechsler | EU Industry Policy |
| 25 Sep 2025 | Hildegard Bentele | Digital Omnibus |
| 24 Sep 2025 | Andrea Wechsler | EU Industry Policy |
| 17 Sep 2025 | Andreas Glück | Medical Devices |
| 1 Sep 2025 | Axel Voss | Copyright and generative AI |
| 19 Mar 2025 | Michael McNamara | EU Medical Device Regulation |
| 18 Feb 2025 | Aurelijus Veryga | Industry Perspectives and Challenges in Light of Recent Regulatory Developments in the Health and Chemical Sectors |
| 18 Feb 2025 | Vytenis Povilas Andriukaitis | Medical devices regulation |
| 5 Dec 2024 | Andreas Glück | MDR |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.